Oxcarbazepine in glossopharyngeal neuralgia: clinical response and effect on serum lipids.
Luef
Gerhard
G
Department of Neurology, Innsbruck Medical University, Anichstrasse 35, Innsbruck, A-6020, Austria. gerhard.luef@uibk.ac.at
Poewe
Werner
W
D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D002220:Carbamazepine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D002791:Cholesterol, Dietary; D008078:Cholesterol, LDL / Q000097:blood; D005260:Female; D020435:Glossopharyngeal Nerve Diseases / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D006937:Hypercholesterolemia / Q000139:chemically induced*; D008875:Middle Aged; D000078330:Oxcarbazepine
D000927:Anticonvulsants; D002791:Cholesterol, Dietary; D008078:Cholesterol, LDL; D002220:Carbamazepine; D000078330:Oxcarbazepine